Bruce Levine
Barbara & Edwad Netter Professor in Cancer Gene Therapy University of Pennsylvania
Dr. Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, is the Founding Director of the Clinical Cell and Vaccine Production Facility (CVPF) at the University of Pennsylvania. He received a B.A. in Biology from Penn and a Ph.D. in Immunology and Infectious Diseases from Johns Hopkins. He led first-in-human adoptive immunotherapy trials including the first use of a lentiviral vector, gene edited cells, and lentivirally-modified cells to treat cancer. He is co-inventor of the first FDA approved gene therapy (Kymriah) and CAR T cells for leukemia and lymphoma licensed to Novartis, with 33 US patents and over 200 publications. He co-founded Tmunity Therapeutics and Capstan Therapeutics.
Seminars
